396 related articles for article (PubMed ID: 28584111)
1. Phage display and kinetic selection of antibodies that specifically inhibit amyloid self-replication.
Munke A; Persson J; Weiffert T; De Genst E; Meisl G; Arosio P; Carnerup A; Dobson CM; Vendruscolo M; Knowles TPJ; Linse S
Proc Natl Acad Sci U S A; 2017 Jun; 114(25):6444-6449. PubMed ID: 28584111
[TBL] [Abstract][Full Text] [Related]
2. Increased Secondary Nucleation Underlies Accelerated Aggregation of the Four-Residue N-Terminally Truncated Aβ42 Species Aβ5-42.
Weiffert T; Meisl G; Flagmeier P; De S; Dunning CJR; Frohm B; Zetterberg H; Blennow K; Portelius E; Klenerman D; Dobson CM; Knowles TPJ; Linse S
ACS Chem Neurosci; 2019 May; 10(5):2374-2384. PubMed ID: 30793584
[TBL] [Abstract][Full Text] [Related]
3. Structural differences of amyloid-β fibrils revealed by antibodies from phage display.
Droste P; Frenzel A; Steinwand M; Pelat T; Thullier P; Hust M; Lashuel H; Dübel S
BMC Biotechnol; 2015 Jun; 15():57. PubMed ID: 26084577
[TBL] [Abstract][Full Text] [Related]
4. An aggregation inhibitor specific to oligomeric intermediates of Aβ42 derived from phage display libraries of stable, small proteins.
Linse S; Sormanni P; O'Connell DJ
Proc Natl Acad Sci U S A; 2022 May; 119(21):e2121966119. PubMed ID: 35580187
[TBL] [Abstract][Full Text] [Related]
5. Lipid membranes catalyse the fibril formation of the amyloid-β (1-42) peptide through lipid-fibril interactions that reinforce secondary pathways.
Lindberg DJ; Wesén E; Björkeroth J; Rocha S; Esbjörner EK
Biochim Biophys Acta Biomembr; 2017 Oct; 1859(10):1921-1929. PubMed ID: 28564579
[TBL] [Abstract][Full Text] [Related]
6. Ultrastructural evidence for self-replication of Alzheimer-associated Aβ42 amyloid along the sides of fibrils.
Törnquist M; Cukalevski R; Weininger U; Meisl G; Knowles TPJ; Leiding T; Malmendal A; Akke M; Linse S
Proc Natl Acad Sci U S A; 2020 May; 117(21):11265-11273. PubMed ID: 32439711
[TBL] [Abstract][Full Text] [Related]
7. Understanding amyloid fibril nucleation and aβ oligomer/drug interactions from computer simulations.
Nguyen P; Derreumaux P
Acc Chem Res; 2014 Feb; 47(2):603-11. PubMed ID: 24368046
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic potential for amyloid surface inhibitor: only amyloid-β oligomers formed by secondary nucleation disrupt lipid membrane integrity.
Tian Y; Liu J; Yang F; Lian C; Zhang H; Viles JH; Li Z
FEBS J; 2022 Nov; 289(21):6767-6781. PubMed ID: 35670622
[TBL] [Abstract][Full Text] [Related]
9. An anticancer drug suppresses the primary nucleation reaction that initiates the production of the toxic Aβ42 aggregates linked with Alzheimer's disease.
Habchi J; Arosio P; Perni M; Costa AR; Yagi-Utsumi M; Joshi P; Chia S; Cohen SI; Müller MB; Linse S; Nollen EA; Dobson CM; Knowles TP; Vendruscolo M
Sci Adv; 2016 Feb; 2(2):e1501244. PubMed ID: 26933687
[TBL] [Abstract][Full Text] [Related]
10. Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism.
Cohen SI; Linse S; Luheshi LM; Hellstrand E; White DA; Rajah L; Otzen DE; Vendruscolo M; Dobson CM; Knowles TP
Proc Natl Acad Sci U S A; 2013 Jun; 110(24):9758-63. PubMed ID: 23703910
[TBL] [Abstract][Full Text] [Related]
11. Structural Characteristics of Monomeric Aβ42 on Fibril in the Early Stage of Secondary Nucleation Process.
Noda K; Tachi Y; Okamoto Y
ACS Chem Neurosci; 2020 Oct; 11(19):2989-2998. PubMed ID: 32794732
[TBL] [Abstract][Full Text] [Related]
12. N-Terminus Binding Preference for Either Tanshinone or Analogue in Both Inhibition of Amyloid Aggregation and Disaggregation of Preformed Amyloid Fibrils-Toward Introducing a Kind of Novel Anti-Alzheimer Compounds.
Dong M; Zhao W; Hu D; Ai H; Kang B
ACS Chem Neurosci; 2017 Jul; 8(7):1577-1588. PubMed ID: 28406293
[TBL] [Abstract][Full Text] [Related]
13. Resting microglia react to Aβ42 fibrils but do not detect oligomers or oligomer-induced neuronal damage.
Ferrera D; Mazzaro N; Canale C; Gasparini L
Neurobiol Aging; 2014 Nov; 35(11):2444-2457. PubMed ID: 24973120
[TBL] [Abstract][Full Text] [Related]
14. Metal Binding of Alzheimer's Amyloid-β and Its Effect on Peptide Self-Assembly.
Abelein A
Acc Chem Res; 2023 Oct; 56(19):2653-2663. PubMed ID: 37733746
[TBL] [Abstract][Full Text] [Related]
15. Simulations on the dual effects of flavonoids as suppressors of Aβ42 fibrillogenesis and destabilizers of mature fibrils.
Gargari SA; Barzegar A
Sci Rep; 2020 Oct; 10(1):16636. PubMed ID: 33024142
[TBL] [Abstract][Full Text] [Related]
16. Interaction of the molecular chaperone DNAJB6 with growing amyloid-beta 42 (Aβ42) aggregates leads to sub-stoichiometric inhibition of amyloid formation.
Månsson C; Arosio P; Hussein R; Kampinga HH; Hashem RM; Boelens WC; Dobson CM; Knowles TP; Linse S; Emanuelsson C
J Biol Chem; 2014 Nov; 289(45):31066-76. PubMed ID: 25217638
[TBL] [Abstract][Full Text] [Related]
17. Dynamics of protofibril elongation and association involved in Aβ42 peptide aggregation in Alzheimer's disease.
Ghosh P; Kumar A; Datta B; Rangachari V
BMC Bioinformatics; 2010 Oct; 11 Suppl 6(Suppl 6):S24. PubMed ID: 20946608
[TBL] [Abstract][Full Text] [Related]
18. Engineered antibody intervention strategies for Alzheimer's disease and related dementias by targeting amyloid and toxic oligomers.
Robert R; Dolezal O; Waddington L; Hattarki MK; Cappai R; Masters CL; Hudson PJ; Wark KL
Protein Eng Des Sel; 2009 Mar; 22(3):199-208. PubMed ID: 18927231
[TBL] [Abstract][Full Text] [Related]
19. Aβ Oligomer Dissociation Is Catalyzed by Fibril Surfaces.
Dear AJ; Thacker D; Wennmalm S; Ortigosa-Pascual L; Andrzejewska EA; Meisl G; Linse S; Knowles TPJ
ACS Chem Neurosci; 2024 Jun; 15(11):2296-2307. PubMed ID: 38785363
[TBL] [Abstract][Full Text] [Related]
20. Amyloid Fibril Formation of Arctic Amyloid-β 1-42 Peptide is Efficiently Inhibited by the BRICHOS Domain.
Zhong X; Kumar R; Wang Y; Biverstål H; Ingeborg Jegerschöld C; J B Koeck P; Johansson J; Abelein A; Chen G
ACS Chem Biol; 2022 Aug; 17(8):2201-2211. PubMed ID: 35876740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
